Proligo® Reagents are manufactured under a strict quality system. All key intermediates are controlled with stringent in-process controls and/or quality specifications in order to exercise maximum control on final product quality. In-process controls are established for critical parameters while manufacturing processes are constantly monitored and routinely reviewed. A dedicated process technology group provides the basis for continuous improvement.
We have over 30 years of experience supplying diagnostic and pharmaceutical industries, during which it has conducted a history of successful site audits.
CCN mitigates the inherent risk associated with a stable and reliable supply. The program is available with quality agreements in place and commits to notify customers of changes related to: